Patents Assigned to VaxEquity Ltd
  • RNA CONSTRUCT
    Publication number: 20250051798
    Abstract: The invention relates to RNA constructs, and particularly, although not exclusively, to mRNA constructs and saRNA replicons and to nucleic acids and expression vectors encoding such RNA constructs. The invention extends to the use of such RNA constructs in therapy, for example in treating diseases and/or in vaccine delivery. The invention extends to pharmaceutical compositions comprising such RNA constructs, and methods and uses thereof.
    Type: Application
    Filed: December 16, 2022
    Publication date: February 13, 2025
    Applicants: Imperial College Innovations Limited, VaxEquity Ltd
    Inventors: Paul McKay, Robin Shattock
  • RNA CONSTRUCT
    Publication number: 20240124530
    Abstract: The present invention relates to RNA constructs, and particularly, although not exclusively, to mRNA constructs and saRNA replicons and to nucleic acids and expression vectors encoding such RNA constructs. The invention extends to the use of such RNA constructs in therapy, for example in treating diseases and/or in vaccine delivery. The invention extends to pharmaceutical compositions comprising such RNA constructs, and methods and uses thereof.
    Type: Application
    Filed: December 17, 2021
    Publication date: April 18, 2024
    Applicants: Imperial College Innovations Limited, VaxEquity Ltd
    Inventors: Robin Shattock, Paul McKay, Michael Watson, Elaine Harper
  • RNA CONSTRUCT
    Publication number: 20230364226
    Abstract: The invention relates to RNA constructs, and particularly, although not exclusively, to mRNA constructs and saRNA replicons and to nucleic acids and expression vectors encoding such RNA constructs. The invention extends to the use of such RNA constructs in therapy, for example in treating diseases and/or in vaccine delivery. The invention extends to pharmaceutical compositions comprising such RNA constructs, and methods and uses thereof.
    Type: Application
    Filed: December 17, 2021
    Publication date: November 16, 2023
    Applicants: Imperial College Innovations Limited, VaxEquity Ltd
    Inventors: Robin Shattock, Paul McKay, Michael Watson, Elaine Harper